1. Home
  2. SPRO vs EFSI Comparison

SPRO vs EFSI Comparison

Compare SPRO & EFSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

HOLD

Current Price

$2.20

Market Cap

156.3M

Sector

Health Care

ML Signal

HOLD

Logo Eagle Financial Services Inc

EFSI

Eagle Financial Services Inc

HOLD

Current Price

$41.64

Market Cap

185.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SPRO
EFSI
Founded
2013
1881
Country
United States
United States
Employees
N/A
231
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
156.3M
185.5M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
SPRO
EFSI
Price
$2.20
$41.64
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$41.50
AVG Volume (30 Days)
1.6M
29.6K
Earning Date
05-13-2026
04-23-2026
Dividend Yield
N/A
3.26%
EPS Growth
111.81
N/A
EPS
N/A
N/A
Revenue
$66,802,000.00
N/A
Revenue This Year
N/A
$31.93
Revenue Next Year
$300.00
$4.38
P/E Ratio
N/A
$24.38
Revenue Growth
39.24
N/A
52 Week Low
$1.80
$28.98
52 Week High
$3.09
$44.00

Technical Indicators

Market Signals
Indicator
SPRO
EFSI
Relative Strength Index (RSI) 36.21 61.53
Support Level $2.19 $38.38
Resistance Level $2.47 N/A
Average True Range (ATR) 0.26 1.18
MACD -0.07 -0.02
Stochastic Oscillator 22.29 55.26

Price Performance

Historical Comparison
SPRO
EFSI

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

About EFSI Eagle Financial Services Inc

Eagle Financial Services Inc is a locally owned and managed financial institution. It offers retail and commercial banking services, including demand, savings and time deposits and consumer, mortgage, and commercial loans. It also offers telephone banking, internet banking, and mobile banking to its customers. The Company has three reportable operating segments, Community Banking, Marine Lending and Wealth Management. It generates a majority of its revenue from the Community Banking segment.

Share on Social Networks: